No Picture
News

U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for KEYTRUDA® (pembrolizumab) to Identify Patients with Microsatellite Instability-High (MSI-H) Solid Tumors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that it received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne CDx to be used as a companion diagnostic to identify patients with Microsatellite Instability […]

No Picture
News

$26.7 Billion Adult Vaccine Market Outlook, 2027 Featuring Key Players – GSK, Merck & Co, Sanofi Pasteur, Pfizer, and CSL Limited

DUBLIN: DUBLIN, Feb. 18, 2022 /PRNewswire/ — The "Global Adult Vaccine Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com’s offering. Adult Vaccine Market expected […]

No Picture
News

European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

DARMSTADT, Germany–(BUSINESS WIRE)–Merck, a leading science and technology company, today announced that the European Commission (EC) has approved once-daily oral TEPMETKO® (tepotinib) as monotherapy for the treatment of adult patients with advanced non-small cell lung […]